Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.

× No keyword cloud information.

7 in total

1. Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma.

Authors: Kota Sahara; Diamantis I Tsilimigras; Junya Toyoda; Kentaro Miyake; Cecilia G Ethun; Shishir K Maithel; Daniel E Abbott; George A Poultsides; Ioannis Hatzaras; Ryan C Fields; Matthew Weiss; Charles Scoggins; Chelsea A Isom; Kamran Idrees; Perry Shen; Yasuhiro Yabushita; Ryusei Matsuyama; Itaru Endo; Timothy M Pawlik
Journal: Ann Surg Oncol Date: 2021-03-11 Impact factor: 5.344

Review 2. Improving outcomes in pancreatic cancer: key points in perioperative management.

Authors: José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo
Journal: World J Gastroenterol Date: 2014-10-21 Impact factor: 5.742

3. Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells in vitro.

Authors: Jinhui Zhu; Yun Ji; Yuanquan Yu; Yun Jin; Xiaoxiao Zhang; Jiale Zhou; Yan Chen
Journal: Oncol Lett Date: 2018-03-28 Impact factor: 2.967

7. Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?

Authors: A Azmy; S Abdelwahab; M Yassen
Journal: ISRN Oncol Date: 2013-02-24

7 in total

Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.

1. Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma.

Review 2. Improving outcomes in pancreatic cancer: key points in perioperative management.

3. Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells in vitro.

4. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study.

Review 5. MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis.

6. Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer.

7. Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?